Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suhuang Cough Capsule for Cough in Acute Exacerbation of COPD
ChiCTR2200061495Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Suhuang cough capsule + conventional treatment with Placebo + conventional treatment (2 arms). Primary endpoint: Visual analog score improvement rate. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
suhuang antitussive capsule
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2200061495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061495.